Product Information
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1805 per EA under NDC 65862077930. Its NADAC has been published 484 times since May 17, 2017.
FDA first approved this application on Apr 24, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB
Olmesartan Medoxomil and HydrochlorothiazideStrength
12.5; 20 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862077930
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILApproval Type
Generic (ANDA)
FDA Application
ANDA205391FDA Approved
4/24/2017
TE Code
AB
On Market Since
4/24/2017
Pharmacological Classes
Price Statistics
The NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 484 times since May 17, 2017, and over the history we have for it it has declined 95.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1805 per EA |
|---|---|
| All-time high | $3.7489 (Jun 14, 2017) |
| All-time low | $0.1437 (Oct 17, 2018) |
| 52-week high | $0.1935 |
| 52-week low | $0.1669 |
| Median price | $0.1992 |
| Average price | $0.2796 |
| Largest weekly change | -93.3% (Jul 19, 2017) |
| Weeks tracked | 484 |
| Tracking since | May 17, 2017 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.1805 per EA (NDC 65862077930), effective Aug 19, 2026.
How has the price of OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 95.2%. It has been tracked across 484 weekly CMS publications since May 17, 2017.
What are the highest and lowest recorded NADAC prices for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since May 17, 2017, the NADAC for OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.1437 (Oct 17, 2018) to a high of $3.7489 (Jun 14, 2017), with a median of $0.1992 per EA.
Are there cheaper alternatives to OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
OLMESARTAN-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 65862077930) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.